We describe the case of a 33-year-old man, a chronic user of powder cocaine, who presented with dyspnea, fever, night sweats, and significant weight loss. Chest HRCT revealed centrilobular nodules, giving an initial impression of miliary tuberculosis. Therefore, he was started on an empirical, four-drug antituberculosis treatment regimen.
INTRODUCTION
Physicians frequently encounter cocaine abuse in clinical practice. It is the leading cause of illicit drug-related deaths worldwide. (1) Cocaine is abused by multiple methods, the snorting of powder cocaine being the most common. Pulmonary complications, such as alveolitis, barotrauma, talcosis, organizing pneumonia, bullous emphysema, and pulmonary fibrosis, are frequently reported as a result of crack cocaine smoking or intravenous cocaine use. (2) However, there has been only one report to date of pulmonary foreign body granulomatosis (PFBG) secondary to cocaine snorting. 
CASE REPORT
A 33-year-old Hispanic male of average build was admitted to our facility, complaining of dyspnea, fever, night sweats, and rapid weight loss (18 kg over a fourmonth period). A pertinent positive finding on the initial history taking was his having traveled to a country where tuberculosis is endemic. Physical examination revealed no acute distress and no stigmata of intravenous drug abuse. He was febrile (≤ 38.5°C), with a blood pressure of 124/72 mmHg, a heart rate of 76 bpm, a respiratory rate of 18 breaths/min, and a constant SpO 2 at rest of 98%. The initial total leukocyte count was 8,200 cells/µL, with a predominant neutrophilic reaction. Blood culture was negative for aerobic and anaerobic microorganisms. Urine toxicology and HIV tests were negative. Chest X-ray and HRCT showed micronodules (1-3 mm in size) bilaterally in centrilobular distribution ( Figure 1 ). An IFN-γ assay and sputum smear microscopy for acid-fast bacilli were carried out in order to rule out mycobacterial infection. Although the results were negative for tuberculosis, the high clinical suspicion of the disease prompted empirical initiation of the four-drug antituberculous therapy. Four weeks later, the patient returned to the emergency room with worsening of the shortness of breath. A repeat HRCT revealed similar centrilobular nodules with no radiological improvement (Figure 2 ). At that time, bronchoscopy with transbronchial lung biopsy was performed for further evaluation of the pulmonary micronodules. Examination of the BAL fluid, with Ziehl-Neelsen staining, revealed no acid-fast bacilli. Histopathological analysis of the transbronchial lung biopsy specimen showed multiple granulomas with birefringent material in the center (Figure 3) , confirming the diagnosis of PFBG. The patient strongly denied intravenous drug use. Unfortunately, he experienced a progressive course with a further decline in his lung function. After progressive fibrosis over the following one-year period, the patient died of chronic respiratory failure.
DISCUSSION
The lungs are frequently affected by cocaine abuse, regardless of the delivery method. Clinical presentation and radiological findings are varied and highly nonspecific. (4) PFBG is a rare condition, and its true incidence is unknown. It is commonly encountered secondary to intravenous injection of pulverized pharmaceutical tablets containing insoluble binders, such as talc, cellulose, starch, and other street adulterants. The tiny particles lodge in the vascular bed and interstitium to cause granulomatous reactions and fibrosis. (5) Prior to this report, there had been only one reported case of PFBG in a user of powder cocaine (intranasal route), which was determined to be caused by cellulose filler. (3) Radiologically, PFBG can present as small diffuse centrilobular nodules, conglomerated masses, diffuse ground-glass opacities, and lower-lobe panlobular emphysema. (6) Because our patient was inhaling cocaine, the appearance of centrilobular nodules on chest CT was consistent with small airway disease, as opposed to miliary tuberculosis, which usually presents as random nodules. It is prudent to consider rare granulomatous conditions such as PFBG in patients with a history of intravenous or inhaled drug abuse. The course of PFBG can be subacute (with fever, weight loss, or hemoptysis) or chronic (with dyspnea and a progressive decline in lung function). (7) Late complications include pulmonary hypertension, cor pulmonale, panlobular emphysema, and, rarely, respiratory failure requiring lung transplantation. (8, 9) There is no specific treatment for PFBG. A few patients have experienced stabilization of symptoms after cessation of drug use and resolution of acute symptoms with corticosteroid use. (10) Avoidance of exposure continues to be the cornerstone of management. 
